Articles tagged with Inflammation
A drug called URMC-099 reversed liver inflammation and scarring in mice with non-alcoholic fatty liver disease. The research suggests that the drug may help treat a growing health concern in the US, affecting over 64 million people.
Scientists have identified a crucial mechanism by which cells detect and respond to DNA damage, shedding light on the body's natural surveillance systems. This discovery may help explain how the human body keeps disease in check and could lead to new therapeutic approaches for cancer prevention.
Researchers found a molecular link between obesity, inflammation, and cardiovascular diseases. Targeting thrombin with dabigatran protected mice from diet-induced obesity-related disease.
A clinical trial found that an Alzheimer's medication, galantamine, reduces inflammation and insulin resistance in patients with metabolic syndrome. The study showed a 25% decrease in inflammatory markers and improved insulin levels.
Researchers found that titanium dioxide nanoparticles can increase inflammation and damage to the intestinal mucosa in mice with colitis. Patients with colitis are recommended to avoid foods containing E171, a food additive made from titanium dioxide.
Physical activity has strong anti-inflammatory properties, playing a crucial role in chronic diseases like type 2 diabetes and cardiovascular disease. Exercise stimulates cytokines IL-6 and IL-10, inhibiting TNF-α and limiting IL-1β signalling to combat inflammation.
Researchers have identified a new target for treating inflammatory skin conditions by depleting the RIPK1 protein. This finding offers a potential 'upstream' approach to treating conditions such as psoriasis, which currently rely on immune suppressant treatments with potential complications.
Scientists at Imperial College London discovered a way to reprogram macrophages, immune cells that cause inflammation, by blocking a single enzyme. By targeting this broken metabolism, they reduced inflammation in rats and mice with human-like diseases.
Researchers developed a metric to identify dangerous blood vessel plaques from CT scans, correlating with markers of inflammation. This new measure may help doctors deploy preventative interventions for at-risk patients, offering a more effective diagnostic tool than current methods.
Researchers at Case Western Reserve University found that a high fat diet rich in plant-derived 'good' fats reduced bacterial diversity and inflammation in mice with Crohn's-like disease. This discovery could lead to new anti-inflammatory probiotics and provide hope for patients suffering from debilitating intestinal symptoms.
Gulf War veterans experience long-term side effects of their service due to exposure to chemicals like pyridostigmine bromide, DEET, and permethrin. Animal models demonstrate how these chemicals cause brain dysfunction, inflammation, and oxidative stress, leading to symptoms such as cognitive decline, memory problems, and chronic fatigue.
Post-operative ileus or bowel paralysis occurs when intestinal contents pass slowly or not at all. New research shows that monocytes help restore bowel function, contrary to initial assumptions.
Researchers found long-term retinal injury and inflammation after blast exposure, even without detectable brain damage. The retina may serve as a sensitive indicator of low-level blast injury, helping identify individuals at risk of visual impairment.
Professor Michael Sieweke has been awarded the Humboldt Professorship at TU Dresden, a prestigious grant worth up to €5 million. He will focus on mechanisms of blood formation and tissue regeneration, with potential applications in cellular therapy and immune system recovery.
Researchers at the Wyss Institute have developed a bacterial sensor that retains long-term memory of gut inflammation, detecting tetrathionate up to six months after administration in a mouse model. This innovation could lead to non-invasive diagnosis and monitoring of conditions like IBD using probiotics.
Researchers at KAUST have identified the molecular liaison responsible for promoting inflammation in endothelial tissues. They found that CD44 and PSGL-1 are key E-selectin ligands involved in this process.
Researchers at Ben-Gurion University have developed a new biomedical polymer that targets damaged tissue, reducing existing plaque and preventing further progression and inflammation. The therapy has shown promising results in mice, improving myocardial function, decreasing inflammation, and thinning arteries.
The graphene-based sensor accurately measures nitrite in exhaled breath condensate, providing a promising biomarker for inflammation in the respiratory tract. This innovation has the potential to improve asthma management, prevent hospitalizations, and reduce deaths worldwide.
A study found that Americans with systemic sclerosis had a greater imbalance of good and bad gut bacteria compared to Norwegians. The researchers believe this difference is due to genetics and diet, which could lead to new treatments by restoring balance through diet modification, probiotics, and fecal transplantation.
A recent study reveals that microRNA-223 plays a crucial role in regulating intestinal inflammation in inflammatory bowel disease. Synthetic versions of this microRNA can reduce inflammation in mice and may hold promise as a future therapy for IBD patients.
Researchers discovered a chemical signal linked to life-threatening lung inflammation, pointing towards new therapies. Blocking molecular signalling mechanisms in patients with Acute Respiratory Distress Syndrome (ARDS) alleviated lung inflammation.
Researchers discovered graphene can withstand extreme pressures, potentially increasing desalination efficiency. Graphene-based filtration membranes may enable more productive desalination processes.
A study found that pretreatment HIV levels and immune activation are linked to persistent inflammation during treatment, contradicting previous results. The research suggests that diagnosing HIV early may prevent elevated immune activation, leading to health problems like heart disease.
A research team at St. Jude Children's Research Hospital has revealed a previously unknown immune machinery underlying neutrophilic dermatosis, a group of autoinflammatory skin disorders. By mapping the biological pathways involved, the researchers identified key molecules and signaling nodes that drive inflammation and tissue damage.
A recent study reveals that overexpression of the Cd14 gene offers protection against inflammatory bowel disease in mice, enhancing intestinal barrier function. The research suggests that soluble Cd14 could be an interesting new therapeutic target for future clinical research.
Researchers at McMaster University found that imbalances in gut microbes lead to intestinal leakage, triggering inflammation, impaired immune function, and reduced lifespan. The study suggests targeting age-associated inflammation may improve immune health and reduce the risk of chronic conditions.
A mouse study reveals that gut microbes play a crucial role in age-associated inflammation and premature death. Imbalances in the gut microbiome lead to leaky intestines and trigger inflammation. Researchers hope to develop drugs or probiotics to restore gut barrier function and reduce age-related inflammation.
A new review suggests that augmenting the function of HDL cholesterol rather than increasing its concentration is crucial for protecting against cardiovascular disease. The study highlights the importance of addressing adipose tissue-associated inflammation to support the atheroprotective role of HDL.
A new study reveals a significant decrease in airway wall cells and certain inflammatory cells in smokers and mild to moderate COPD patients. The findings challenge the widely accepted description of airway inflammation in these individuals, suggesting a more complex underlying mechanism.
Researchers at Rockefeller University have discovered that changes in the vascular system and a plasma component called Factor XII may trigger Alzheimer's disease. The study suggests that targeting this process could lead to early diagnosis and new treatments for the condition.
Researchers found that adding back beneficial bacteria can help end a cycle of unchecked inflammation, suggesting a new treatment for inflammatory bowel disease. The study suggests targeting the inflammation downstream of NLRP12 with anti-inflammatory drugs or feeding specific beneficial bacteria to potentially lead to treatments.
Researchers have identified a new compound that binds to CD11b and enhances its ability to suppress TLR signaling, reducing inflammation in lupus patients. The study found that the compound can override genetic defects associated with ITGAM mutations, offering a personalized approach to treating lupus.
Researchers found that IL-21 producing CD4+ T cells contribute to joint inflammation by activating synovial fibroblasts. This discovery holds promise for targeted therapies to decrease inflammation and improve quality of life for patients.
A recent study suggests that a ketogenic diet can protect against gout flares in rats by increasing levels of ketone bodies and inhibiting the NLRP3 inflammasome. This could potentially improve treatment outcomes for humans with the disease.
Researchers developed an assay to detect autoantibodies present in rheumatoid arthritis patients, finding that memory B cells secrete these molecules. The study suggests targeting these immune system cells could lead to a cure for the disease.
Researchers propose a new therapy for Gaucher disease by blocking the molecule C5aR1, which drives inflammation and organ damage. The treatment may offer fewer risks and lower costs than current therapies.
Researchers have identified interleukin-1 beta (IL-1) as the trigger for inflammation during necroptosis, a recently described form of cell death. This discovery could lead to new treatments for inflammatory diseases such as psoriasis and inflammatory bowel disease by targeting IL-1.
A study by Ohio State University researchers found that a Mediterranean diet rich in anti-inflammatory foods such as seafood and plant-based proteins can help reduce pain associated with obesity. The study also highlights the importance of diet quality over quantity in managing weight-related pain.
Research using mutant zebrafish models human disease to show that changes in certain gut bacteria can cause intestinal inflammation. Transplanting beneficial bacteria and restoring gut neurons also cured the disease.
A new RNAi treatment has shown significant improvement in mouse models of acute uveitis and chronic diabetic inflammation without apparent side effects. The therapy targets the receptor-associated prorenin system, involved in uveitis pathogenesis.
New research uncovers a connection between Crohn's disease and spondyloarthritis, finding that IgA-coated E. coli bacteria trigger inflammation in Th17 cells. This discovery may lead to the development of diagnostic tools and therapies targeting both conditions.
A study led by UT Southwestern Medical Center researchers uncovered molecular pathways behind gut bacterial imbalance during inflammatory episodes. The findings provide insights into developing new prevention and treatment strategies for conditions like IBD, colorectal cancers, and gastrointestinal infections.
Researchers at UTMB have identified inflammation as a major contributor to permanent vision loss after head trauma. Limiting inflammation may help preserve cell function and prevent nerve damage.
Virginia Tech researchers have discovered that modifying IRAK-M protein can significantly reduce inflammation and cancer progression in pre-clinical animal models. The team's findings suggest that designing therapeutics targeting IRAK-M could be a viable strategy for preventing these diseases.
A new study suggests that an anti-inflammatory diet rich in vegetables, fruits, fish, and whole grains can help prevent bone loss and fractures in post-menopausal white women younger than 63. The researchers found a correlation between lower-inflammatory diets and lower risk of hip fracture in this subgroup.
The GSG III Foundation has pledged over $1 million for a new research program at the University of Louisville, aiming to develop better methods for studying lung inflammation and explore potential therapies. The program will focus on chronic obstructive pulmonary disease (COPD), cystic fibrosis, and asthma.
A new study reveals that individuals with Type 1 diabetes exhibit distinct gut inflammation and microbiome changes compared to those without diabetes or celiac disease. The research found specific genes associated with gut inflammation and unique combinations of gut bacteria in patients with Type 1 diabetes.
A study by MGH and ISSMS investigators has linked brain activity to cardiovascular disease, identifying a pathway from the amygdala through inflammation to cardiovascular events. Elevated amygdalar activity was strongly associated with increased risk of heart attack and stroke.
A high-fiber diet triggers microorganisms in the gut to produce short-chain fatty acids, which induce neutrophil apoptosis and resolution of inflammation. This finding has important implications for treating gout and possibly other inflammatory diseases.
Researchers discovered that replacing missing gut bacteria or restoring a key metabolite called inosine could help treat children with IPEX syndrome, an often fatal autoimmune disease. The study found that probiotic Lactobacillus reuteri and A2A receptor agonists inhibited T cell-mediated autoimmunity, extending the animals' life span.
Researchers have identified a key role for ZG16 in protecting the body from intestinal bacteria, preventing inflammation and abdominal fat accumulation. The discovery provides new insights into the mechanisms of inflammatory bowel diseases and obesity.
New research from Brigham Young University finds that running decreases pro-inflammatory molecules in the knee joint, reducing inflammation. The study suggests exercise can be a type of medicine for preventing osteoarthritis and delaying its onset.
A new study found that the mannitol challenge test may not be accurate in detecting asthma in non-clinical settings. The test's predictive value was low in the general population, highlighting the need for caution when interpreting results.
Researchers found that IL-12 has a positive effect on skin affected by psoriasis, preventing pathogenic immune cell infiltration and inhibiting inflammatory reactions. The current treatment ustekinumab neutralizes both IL-23 and IL-12, potentially leading to counterproductive effects.
Researchers discovered that targeting the TGF-β1 pathway can reduce pro-inflammatory signals and improve motor function in mice after intracerebral hemorrhage. In human patients, higher levels of TGF-β1 within the first 3 days following stroke predicted better outcomes three months into recovery.
Researchers found that diabetes causes a specific inflammation leading to heart arrhythmias. Two promising drugs inhibit this inflammatory process, reversing cardiac alterations in diabetic mice.
A recent study found that low-fat diets and regular exercise can reduce liver inflammation and scarring in patients with non-alcoholic steatohepatitis. Additionally, improved liver health was associated with enhanced kidney function in these individuals, independent of other factors such as diabetes or weight loss.
New research published in The FASEB Journal suggests that IL-10 may protect against the normal insulin resistance associated with aging. Scientists used transgenic mice to show that IL-10 helped reduce inflammation and insulin resistance in skeletal muscle, a significant step toward improving quality of life as people age.
Researchers at the University of Edinburgh found that a drug called AT7519 helps restore normal function in neutrophils, which contribute to ARDS. The treatment approach shows promise for resolving inflammation in the lung and improving patient outcomes.
Researchers identify direct link between brain inflammation and CTE, with longer football careers predicting increased inflammation and disease progression. The study suggests that treating inflammation could prevent or lessen CTE development, offering potential biomarkers for early identification.